Search Within

Jason T Huse

Formats
  1. Journal Article (98)
  2. Meeting Abstract (45)
Groups
  1. GSK Faculty (71)
  2. Department of Pathology and Laboratory Medicine (50)
  3. Sloan Kettering Institute Postdocs (45)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (44)
  5. Surgery (43)
  6. Tow Center for Developmental Oncology (TCDO) (43)

More Groups

People
  1. Cameron Brennan (36)
  2. Eric Holland (27)
  3. Timothy Chan (24)
  4. Nikolaus Schultz (22)
  5. Chris Sander (18)
  6. Marc Rosenblum (15)

More People

Years
  1. 2020 (14)
  2. 2018 (1)
  3. 2017 (7)
  4. 2016 (12)
  5. 2015 (18)
  6. 2014 (20)

More Years

Publications
  1. Neuro-Oncology (28)
  2. Cancer Research (10)
  3. Journal of Neuropathology and Experimental Neurology (10)
  4. Nature Communications (10)
  5. Clinical Cancer Research (6)
  6. Journal of Clinical Oncology (5)

More Publications

Publishers
  1. Oxford University Press (38)
  2. Nature Publishing Group (22)
  3. American Association for Cancer Research (18)
  4. Cell Press (10)
  5. Springer (6)
  6. American Society of Clinical Oncology (5)

More Publishers

Results (143)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brain Malignancy Steering Committee clinical trials planning workshop: Report from the Targeted Therapies Working Group
    Journal Article

    Alexander, B. M.; Galanis, E.; Yung, W. K. A.; Ballman, K. V.; Boyett, J. M.; Cloughesy, T. F.; DeGroot, J. F.; Huse, J. T.; Mann, B.; Mason, W.; more...
    Neuro-Oncology (2015)

    Fulltext@MSK | Save
  • The evolving molecular genetics of low-grade glioma
    Journal Article

    Venneti, S.; Huse, J. T.
    Advances in Anatomic Pathology (2015)

    Fulltext@MSK | Save
  • Glioma-associated IDH mutation induces miR-34a repression and stem cell-like physiology through enhanced PDGF signaling
    Meeting Abstract

    Silber, J.; Harinath, G.; Parthasarathy, P. T.; Fabius, A. W. M.; Turcan, S.; Chan, T. A.; Huse, J. T.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • TERT promoter mutation, IDH mutation and 1p/19q codeletion define five glioma molecular groups with specific clinical characteristics and germline variant associations
    Meeting Abstract

    Eckel-Passow, J.; LaChance, D.; Walsh, K.; Decker, P.; Sicotte, H.; Pekmezci, M.; Molinaro, A.; Rice, T.; Kosel, M.; Smirnov, I.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • TERT promoter mutation designates biologically aggressive primary glioblastoma
    Journal Article

    Huse, J. T.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • CMV and glioma - Are we there yet?
    Journal Article

    Huse, J. T.; Aldape, K.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • The evolving role of molecular markers in the diagnosis and management of diffuse glioma
    Journal Article

    Huse, J. T.; Aldape, K. D.
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Elucidating the oncogenic role of Atrx deficiency in glioma
    Meeting Abstract

    Huse, J. T.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma
    Journal Article

    Omuro, A.; Beal, K.; Gutin, P.; Karimi, S.; Correa, D. D.; Kaley, T. J.; Deangelis, L. M.; Chan, T. A.; Gavrilovic, I. T.; Nolan, C.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Radiographic features, patterns of treatment failure, and clinical outcomes in 56 cases of molecularly subtyped glioblastoma multiforme patients
    Meeting Abstract

    Laplant, Q.; Pitter, K.; Young, R. J.; Yamada, Y.; Chan, T. A.; Huse, J. T.; Brennan, C. W.; Beal, K.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save